Effect of camostat mesilate on persistent proteinuria of IgA nephropathy.
Matsubara
M
M
Taguma
Y
Y
Saito
T
T
Yoshinaga
K
K
D000284:Administration, Oral; D000328:Adult; D004952:Esters; D005260:Female; D016670:Gabexate / Q000031:analogs & derivatives*; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D006146:Guanidines / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011507:Proteinuria / Q000150:complications / Q000188:drug therapy* / Q000652:urine
D004952:Esters; D006146:Guanidines; D011480:Protease Inhibitors; C034532:camostat; D016670:Gabexate